NCEL

NewcelX Ltd

• PUBT·07/15 13:50

  NewcelX wins Brazil patent for NCEL-101 Type 1 diabetes manufacturing process through 2036

• TipRanks·07/15 13:15

  NewcelX announces Brazil patent for cell selection, enrichment technology

• Reuters·07/15 13:07

  NEWCELX AG - GRANTED BRAZILIAN PATENT FOR NCEL-101 MANUFACTURING PROCESS UNTIL NOVEMBER 2036

• PUBT·07/15 13:03

  NewcelX wins Brazil patent for NCEL-101 manufacturing process through 2036

• Benzinga·07/15 13:01

  NewcelX Issued Patent From Brazilian Patent And Trademark Office For Its Nnovative Cell Selection And Enrichment Technology

• Dow Jones·07/13 11:38

  NewcelX Initiated at Buy by Laidlaw & Co.

• Dow Jones·07/13 11:38

  NewcelX Price Target Announced at $23.00/Share by Laidlaw & Co.

• Benzinga·07/13 11:28

  Laidlaw & Co. Initiates Coverage On NewcelX with Buy Rating, Announces Price Target of $23

• TipRanks·07/13 09:00

  NewcelX initiated with a Buy at Laidlaw

• TipRanks·07/08 13:47

  NewcelX Strengthens Diabetes Push With Appointment of Leading Transplant Pioneer Camillo Ricordi

• PUBT·07/08 13:15

  NewcelX appoints diabetes researcher Camillo Ricordi to scientific advisory board

• PUBT·07/02 18:32

  NewcelX reports successful FDA pre-IND meeting for NCEL-101 type 1 diabetes trial plan

• TipRanks·07/01 13:58

  NewcelX Wins FDA Backing to Advance NCEL-101 Toward Type 1 Diabetes Trials

• TipRanks·07/01 13:35

  NewcelX completes Type B Pre-IND meeting with FDA for NCEL-101

• Benzinga·07/01 13:33

  NewcelX Completes Type B Pre-IND Meeting With FDA; Administration Provided Constructive Feedback And Alignment On Proposed Strategy